loadpatents
name:-0.012769937515259
name:-0.015316009521484
name:-0.00057601928710938
Michejda; Christopher J. Patent Filings

Michejda; Christopher J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Michejda; Christopher J..The latest application filed is for "peptide-based stat inhibitor".

Company Profile
0.14.10
  • Michejda; Christopher J. - North Potomac MD
  • Michejda, Christopher J - Potomac MD
  • Michejda, Christopher J - North Potomac MD
  • Michejda, Christopher J. - Potomac MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Peptide-based Stat Inhibitor
App 20170204148 - Tarasova; Nadya I. ;   et al.
2017-07-20
Peptide-based stat inhibitor
Grant 9,540,427 - Tarasova , et al. January 10, 2
2017-01-10
Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs
Grant 9,326,950 - Tarasova , et al. May 3, 2
2016-05-03
Azonafide derived tumor and cancer targeting compounds
Grant 8,008,316 - Tarasova , et al. August 30, 2
2011-08-30
Peptide-based Stat Inhibitor
App 20100184697 - Tarasova; Nadya I. ;   et al.
2010-07-22
Azonafide Derived Tumor And Cancer Targeting Compounds
App 20100120817 - Tarasova; Nadya I. ;   et al.
2010-05-13
Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs
App 20100034896 - Tarasova; Nadya I. ;   et al.
2010-02-11
Inhibition of ABC transporters by transmembrane domain analogs
Grant 7,517,849 - Tarasova , et al. April 14, 2
2009-04-14
Maleiimide anti-tumor phosphatase inhibitors
Grant 7,504,430 - Michejda, legal representative , et al. March 17
2009-03-17
Maleiimide anti-tumor phosphatase inhibitors
App 20080039518 - Michejda; Christopher J. ;   et al.
2008-02-14
G protein-coupled receptor antagonists
Grant 7,105,488 - Tarasova , et al. September 12, 2
2006-09-12
Conjugates of ligand linker and cytotoxic agent and related composition and methods of use
App 20050171014 - Tarasova, Nadya I ;   et al.
2005-08-04
Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
Grant 6,894,068 - Michejda , et al. May 17, 2
2005-05-17
1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity
Grant 6,664,263 - Cholody , et al. December 16, 2
2003-12-16
1,8-naphthalimide Imidazo{4,5,1-de}acridones With Anti-tumor Activity
App 20030203916 - Cholody, Wieslaw M ;   et al.
2003-10-30
Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
App 20030191160 - Michejda, Christopher J. ;   et al.
2003-10-09
Benzoylalkylindolepyridinium componds and pharmaceutical compositions comprising such compounds
App 20020182151 - Rice, William G. ;   et al.
2002-12-05
Substituted benzimidazoles, and methods of use thereof, for the inhibition of HIV reverse transcription and for the treatment of HIV infection
Grant 6,369,235 - Michejda , et al. April 9, 2
2002-04-09
Acridone-derived compounds useful as antineoplastic and antiretroviral agents
App 20010009914 - Michejda, Christopher J. ;   et al.
2001-07-26
2,3-epoxy alcohols, acids and derivatives as anti retroviral chemotherapeutic agents
Grant 6,153,589 - Blumenstein , et al. November 28, 2
2000-11-28
Bistriazenes as chemotherapeutic agents
Grant 5,672,593 - Michejda , et al. September 30, 1
1997-09-30
Bis-acridone chemotherapeutic derivatives
Grant 5,508,289 - Michejda , et al. April 16, 1
1996-04-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed